Open AccessPrevalence of fatty liver in metabolic syndrome
Author(s) -
Anita Goyal,
Hobinder Arora,
Sumit Arora
Publication year - 2020
Publication title -
journal of family medicine and primary care
Language(s) - English
Resource type - Journals
eISSN - 2278-7135
pISSN - 2249-4863
DOI - 10.4103/jfmpc.jfmpc_1108_19
Subject(s) - medicine , metabolic syndrome , fatty liver , hepatocellular carcinoma , cirrhosis , gastroenterology , obesity , disease , liver disease , overweight
In Western world, non-alcohlic fatty liver disease (NAFLD) is considered to be the commonest liver problem, and it is being recognised as a major cause of liver-related morbidity and mortality. As the prevalence of overweight/obesity and metabolic syndrome increases, NASH may become one of the more common causes of end stage liver disease and hepatocellular carcinoma. But much information is not available in this association. So an attempt has been made to correlate both.